Clinical Pathology

Proscia: Delivering a menu of H&E, IHC, and special stains on the Concentriq platform PHILADELPHIA and LOS ANGELES – September 24, 2025 – Proscia®, a pathology AI company, is introducing virtual staining in...

Where are we going? Where have we been? What is the future? Last month, Tempus purchased Paige AI for $81M, largely in the form of Tempus stock to, as reports mention, for PaigeAI's datasets from 7 million slides, perhaps most of...

VISTA, California, September 5, 2025 — In a major leap forward to enable digital transformation of clinical diagnostics, Leica Biosystems proudly showcases its latest, trailblazing additions to the Aperio Digital Pathology portfolio at booth...

The latest from the Proscia blog Emerging biotechs, along with their small and mid-sized CRO counterparts, are establishing themselves as key players advancing the next generation of therapies. So, in line with our mission to rewire...

OREM, Utah--(BUSINESS WIRE)--Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its platform, Techcyte Fusion™ (research use only (RUO) in the US, CE-IVDD-marked in...

OREM, UT, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Techcyte, a leader in AI-powered digital pathology, has signed a distribution agreement with Hamamatsu Corporation (U.S.). This agreement enables Techcyte to streamline access to...